Plain-English translation of NCT07459647 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Schizophrenia research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This is a one-year study testing a medication called in adults with schizophrenia. The research team wants to understand how well this medication works over time and how safe it is to use. You would take the medication regularly and visit the clinic for check-ins and assessments.
Schizophrenia requires long-term treatment to help manage symptoms and improve quality of life. Researchers are studying this medication to see if it can be a safe and effective option for people who need ongoing care.
You likely qualify if…
You likely don't qualify if…
You would take the medication regularly as instructed and attend clinic visits over 52 weeks (one year). At these visits, your doctor will check how you are doing, ask about any side effects, run blood tests or other safety checks, and assess how well the medication is helping your symptoms. The study is open-label, which means both you and your doctor know you are receiving the medication being tested.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
United States